Camacho-Gomez M, Castellvi P. Effectiveness of family intervention for preventing relapse in first-episode psychosis until 24 months of follow-up: a systematic review with meta-analysis of randomized controlled trials [published online May 3, 2019]. Schizophr Bull. doi: https://doi.org/10.1093/schbul/sbz038
Broome MR, Woolley JB, Johns LC, et al. (August 2005). "Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state". Eur. Psychiatry. 20 (5–6): 372–8. doi:10.1016/j.eurpsy.2005.03.001. PMID16171652. S2CID27207646.
Amminger; Schäfer; Papageorgiou; Harrigan; Cotton; McGorry; Berger (2008). "Indicated Prevention of Psychotic Disorders with Long-Chainomega-3 Fatty Acids: A Randomized, Placebo-Controlled Trial". Schizophrenia Research. 102 (1–3): 252. doi:10.1016/s0920-9964(08)70758-8. S2CID53301111.
Preti A, Cella M (2010). "Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness". Schizophrenia Research. 123 (1): 30–36. doi:10.1016/j.schres.2010.07.026. PMID20727717. S2CID28017135.
Schultze-Lutter, F.; Michel, C.; Schmidt, S.J.; Schimmelmann, B.G.; Maric, N.P.; Salokangas, R.K.R.; Riecher-Rössler, A.; van der Gaag, M.; Nordentoft, M.; Raballo, A.; Meneghelli, A.; Marshall, M.; Morrison, A.; Ruhrmann, S.; Klosterkötter, J. (2015). "EPA guidance on the early detection of clinical high risk states of psychoses". European Psychiatry. 30 (3): 405–416. doi:10.1016/j.eurpsy.2015.01.010. ISSN0924-9338. PMID25735810. S2CID20973529.
Falloon I.R. (1992). "Early intervention for first episodes of schizophrenia: A preliminary exploration". Psychiatry. 55 (1): 4–15. doi:10.1080/00332747.1992.11024572. PMID1557469.
Sensky T, Turkington D, Kingdon D, Scott JL, Scott J, Siddle R, O'Carroll M, Barnes TR (February 2000). "A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication". Arch. Gen. Psychiatry. 57 (2): 165–72. doi:10.1001/archpsyc.57.2.165. PMID10665619.
Kuipers E, Garety P, Fowler D, Dunn G, Bebbington P, Freeman D, Hadley C (October 1997). "London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. I: effects of the treatment phase". Br J Psychiatry. 171 (4): 319–27. doi:10.1192/bjp.171.4.319. PMID9373419. S2CID38736138.
McCrone, P.; Knapp, M.; Dhanasiri, S. (2009). "Economic impact of services for first-episode psychosis: a decision model approach". Early Intervention in Psychiatry. 3 (4): 266–273. doi:10.1111/j.1751-7893.2009.00145.x. PMID22642729. S2CID30407696.
Broome MR, Woolley JB, Johns LC, et al. (August 2005). "Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state". Eur. Psychiatry. 20 (5–6): 372–8. doi:10.1016/j.eurpsy.2005.03.001. PMID16171652. S2CID27207646.
Preti A, Cella M (2010). "Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness". Schizophrenia Research. 123 (1): 30–36. doi:10.1016/j.schres.2010.07.026. PMID20727717. S2CID28017135.
Schultze-Lutter, F.; Michel, C.; Schmidt, S.J.; Schimmelmann, B.G.; Maric, N.P.; Salokangas, R.K.R.; Riecher-Rössler, A.; van der Gaag, M.; Nordentoft, M.; Raballo, A.; Meneghelli, A.; Marshall, M.; Morrison, A.; Ruhrmann, S.; Klosterkötter, J. (2015). "EPA guidance on the early detection of clinical high risk states of psychoses". European Psychiatry. 30 (3): 405–416. doi:10.1016/j.eurpsy.2015.01.010. ISSN0924-9338. PMID25735810. S2CID20973529.
Falloon I.R. (1992). "Early intervention for first episodes of schizophrenia: A preliminary exploration". Psychiatry. 55 (1): 4–15. doi:10.1080/00332747.1992.11024572. PMID1557469.
Sensky T, Turkington D, Kingdon D, Scott JL, Scott J, Siddle R, O'Carroll M, Barnes TR (February 2000). "A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication". Arch. Gen. Psychiatry. 57 (2): 165–72. doi:10.1001/archpsyc.57.2.165. PMID10665619.
Kuipers E, Garety P, Fowler D, Dunn G, Bebbington P, Freeman D, Hadley C (October 1997). "London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. I: effects of the treatment phase". Br J Psychiatry. 171 (4): 319–27. doi:10.1192/bjp.171.4.319. PMID9373419. S2CID38736138.
McCrone, P.; Knapp, M.; Dhanasiri, S. (2009). "Economic impact of services for first-episode psychosis: a decision model approach". Early Intervention in Psychiatry. 3 (4): 266–273. doi:10.1111/j.1751-7893.2009.00145.x. PMID22642729. S2CID30407696.
Johannessen JO, McGlashan TH, Larsen TK, et al. (August 2001). "Early detection strategies for untreated first-episode psychosis". Schizophr. Res. 51 (1): 39–46. doi:10.1016/S0920-9964(01)00237-7. PMID11479064. S2CID7361138.
Broome MR, Woolley JB, Johns LC, et al. (August 2005). "Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state". Eur. Psychiatry. 20 (5–6): 372–8. doi:10.1016/j.eurpsy.2005.03.001. PMID16171652. S2CID27207646.
Amminger; Schäfer; Papageorgiou; Harrigan; Cotton; McGorry; Berger (2008). "Indicated Prevention of Psychotic Disorders with Long-Chainomega-3 Fatty Acids: A Randomized, Placebo-Controlled Trial". Schizophrenia Research. 102 (1–3): 252. doi:10.1016/s0920-9964(08)70758-8. S2CID53301111.
Preti A, Cella M (2010). "Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness". Schizophrenia Research. 123 (1): 30–36. doi:10.1016/j.schres.2010.07.026. PMID20727717. S2CID28017135.
Schultze-Lutter, F.; Michel, C.; Schmidt, S.J.; Schimmelmann, B.G.; Maric, N.P.; Salokangas, R.K.R.; Riecher-Rössler, A.; van der Gaag, M.; Nordentoft, M.; Raballo, A.; Meneghelli, A.; Marshall, M.; Morrison, A.; Ruhrmann, S.; Klosterkötter, J. (2015). "EPA guidance on the early detection of clinical high risk states of psychoses". European Psychiatry. 30 (3): 405–416. doi:10.1016/j.eurpsy.2015.01.010. ISSN0924-9338. PMID25735810. S2CID20973529.
Kuipers E, Garety P, Fowler D, Dunn G, Bebbington P, Freeman D, Hadley C (October 1997). "London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. I: effects of the treatment phase". Br J Psychiatry. 171 (4): 319–27. doi:10.1192/bjp.171.4.319. PMID9373419. S2CID38736138.
McCrone, P.; Knapp, M.; Dhanasiri, S. (2009). "Economic impact of services for first-episode psychosis: a decision model approach". Early Intervention in Psychiatry. 3 (4): 266–273. doi:10.1111/j.1751-7893.2009.00145.x. PMID22642729. S2CID30407696.
Schultze-Lutter, F.; Michel, C.; Schmidt, S.J.; Schimmelmann, B.G.; Maric, N.P.; Salokangas, R.K.R.; Riecher-Rössler, A.; van der Gaag, M.; Nordentoft, M.; Raballo, A.; Meneghelli, A.; Marshall, M.; Morrison, A.; Ruhrmann, S.; Klosterkötter, J. (2015). "EPA guidance on the early detection of clinical high risk states of psychoses". European Psychiatry. 30 (3): 405–416. doi:10.1016/j.eurpsy.2015.01.010. ISSN0924-9338. PMID25735810. S2CID20973529.